23.17
price down icon1.99%   -0.47
after-market After Hours: 23.14 -0.03 -0.13%
loading
Sanara Medtech Inc stock is traded at $23.17, with a volume of 45,370. It is down -1.99% in the last 24 hours and up +16.08% over the past month. Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
See More
Previous Close:
$23.64
Open:
$23.7
24h Volume:
45,370
Relative Volume:
0.79
Market Cap:
$212.33M
Revenue:
$103.14M
Net Income/Loss:
$-5.82M
P/E Ratio:
-5.3233
EPS:
-4.3526
Net Cash Flow:
$2.14M
1W Performance:
+10.02%
1M Performance:
+16.08%
6M Performance:
+18.94%
1Y Performance:
-25.23%
1-Day Range:
Value
$22.36
$24.00
1-Week Range:
Value
$20.80
$24.00
52-Week Range:
Value
$16.05
$35.95

Sanara Medtech Inc Stock (SMTI) Company Profile

Name
Name
Sanara Medtech Inc
Name
Phone
817-529-2300
Name
Address
1200 SUMMIT AVE, FORT WORTH
Name
Employee
108
Name
Twitter
Name
Next Earnings Date
2026-05-12
Name
Latest SEC Filings
Name
SMTI's Discussions on Twitter

Compare SMTI vs ISRG, BDX, ALC, MDLN, RMD

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SMTI icon
SMTI
Sanara Medtech Inc
23.17 216.64M 103.14M -5.82M 2.14M -4.3526
ISRG icon
ISRG
Intuitive Surgical Inc
438.10 155.76B 10.58B 3.00B 2.83B 8.2437
BDX icon
BDX
Becton Dickinson Co
147.63 40.30B 21.37B 1.41B 3.07B 3.9437
ALC icon
ALC
Alcon Inc
67.78 33.13B 10.63B 819.00M 1.59B 1.6577
MDLN icon
MDLN
Medline Inc
37.01 31.37B 29.14B 1.07B 1.05B 1.1956
RMD icon
RMD
Resmed Inc
208.05 30.31B 5.54B 1.52B 1.74B 10.37

Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-15-26 Initiated Lake Street Buy
Mar-26-25 Reiterated H.C. Wainwright Buy
Dec-23-24 Initiated H.C. Wainwright Buy
May-20-22 Resumed Cantor Fitzgerald Overweight
Jun-30-21 Initiated Cantor Fitzgerald Overweight

Sanara Medtech Inc Stock (SMTI) Latest News

pulisher
May 25, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

May 25, 2026
pulisher
May 22, 2026

How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put - Yahoo Finance

May 22, 2026
pulisher
May 22, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Shareholders to Connect - ACCESS Newswire

May 22, 2026
pulisher
May 21, 2026

Sanara MedTech (SMTI) Q1 2026 Earnings Beat: Revenue $N/A, EPS $0.05Viral Trade Signals - Newser

May 21, 2026
pulisher
May 21, 2026

Sanara MedTech (SMTI) Q1 2026 Earnings: EPS $0.05 Beats EstimatesEarnings Call Q&A - Newser

May 21, 2026
pulisher
May 21, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc.SMTI - PR Newswire

May 21, 2026
pulisher
May 19, 2026

Pomerantz LLP investigates Sanara MedTech for p... | Pluang – Crypto, Stocks, Gold & Funds - Pluang

May 19, 2026
pulisher
May 18, 2026

Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

May 18, 2026
pulisher
May 18, 2026

Sanara MedTech (SMTI) CEO reports share withholding to cover tax on vested stock - Stock Titan

May 18, 2026
pulisher
May 18, 2026

Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Gr - The National Law Review

May 18, 2026
pulisher
May 15, 2026

The Technical Signals Behind (SMTI) That Institutions Follow - Stock Traders Daily

May 15, 2026
pulisher
May 15, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review

May 15, 2026
pulisher
May 15, 2026

2026-05-15 | Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Stockholders to Inquire about Securities Investigation | NDAQ:SMTI | Press Release - Stockhouse

May 15, 2026
pulisher
May 15, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Investors to Connect - The National Law Review

May 15, 2026
pulisher
May 14, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

May 14, 2026
pulisher
May 14, 2026

Sanara MedTech: From Cash Burner To Profitable Growth (NASDAQ:SMTI) - Seeking Alpha

May 14, 2026
pulisher
May 13, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Investors to Reach Out - ACCESS Newswire

May 13, 2026
pulisher
May 13, 2026

Sanara MedTech Inc. (NASDAQ:SMTI) Q1 2026 Earnings Call Transcript - Insider Monkey

May 13, 2026
pulisher
May 13, 2026

Sanara MedTech Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 13, 2026
pulisher
May 12, 2026

Sanara outlines Q2 2026 net revenue of $28.5M-$29.5M while reaffirming $116M-$121M full-year outlook - MSN

May 12, 2026
pulisher
May 12, 2026

Lake Street Maintains Sanara MedTech(SMTI.US) With Buy Rating, Maintains Target Price $32 - 富途牛牛

May 12, 2026
pulisher
May 12, 2026

Sanara MedTech (SMTI) posts Q1 2026 profit as revenue reaches $27.8M - Stock Titan

May 12, 2026
pulisher
May 12, 2026

Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Stro - GuruFocus

May 12, 2026
pulisher
May 12, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Reach Out - ACCESS Newswire

May 12, 2026
pulisher
May 12, 2026

Sanara MedTech (SMTI) Reports Strong Q1 Revenue Growth and Impro - GuruFocus

May 12, 2026
pulisher
May 12, 2026

2026-05-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Reach Out | NDAQ:SMTI | Press Release - Stockhouse

May 12, 2026
pulisher
May 12, 2026

Earnings call transcript: Sanara MedTech Q1 2026 beats EPS expectations, stock surges - Investing.com

May 12, 2026
pulisher
May 12, 2026

Earnings call transcript: Sanara MedTech Q1 2026 beats EPS expectations, stock surges By Investing.com - Investing.com South Africa

May 12, 2026
pulisher
May 12, 2026

Transcript: Sanara MedTech Q1 2026 Earnings Conference Call - Benzinga

May 12, 2026
pulisher
May 12, 2026

Sanara MedTech Sees 2Q Rev $28.5M-$29.5M >SMTI - Moomoo

May 12, 2026
pulisher
May 12, 2026

Sanara MedTech Q1 2026 Earnings Call Transcript - MarketBeat

May 12, 2026
pulisher
May 12, 2026

Sanara MedTech's Surgical Pivot Delivers Q1 Profitability - BriefGlance

May 12, 2026
pulisher
May 12, 2026

Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

May 12, 2026
pulisher
May 12, 2026

Sanara Medtech earnings beat by $0.08, revenue topped estimates - Investing.com Canada

May 12, 2026
pulisher
May 11, 2026

Is Sanara MedTech (SMTI) Undervalued After a Q1 2026 Earnings Be - GuruFocus

May 11, 2026
pulisher
May 11, 2026

Sanara MedTech Reports Q1 2026: Revenue $27.8M, GAAP Net Income $0.05/share, Adjusted EBITDA $4.3M - TradingView

May 11, 2026
pulisher
May 11, 2026

Sanara MedTech Q1 revenue rises, swings to profit - TradingView

May 11, 2026
pulisher
May 11, 2026

Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited) - The Manila Times

May 11, 2026
pulisher
May 11, 2026

Sanara MedTech Backs 2026 Rev $116M-$121M >SMTI - Moomoo

May 11, 2026
pulisher
May 11, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Connect - ACCESS Newswire

May 11, 2026
pulisher
May 11, 2026

2026-05-11 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Connect | NDAQ:SMTI | Press Release - Stockhouse

May 11, 2026
pulisher
May 11, 2026

Sanara MedTech Inc (SMTI) Q1 2026 Earnings Report Preview: What To Expect - GuruFocus

May 11, 2026
pulisher
May 11, 2026

Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

May 11, 2026
pulisher
May 10, 2026

2026-05-10 | Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | NDAQ:SMTI | Press Release - Stockhouse

May 10, 2026
pulisher
May 08, 2026

Sanara Medtech Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

May 08, 2026
pulisher
May 08, 2026

Sanara MedTech outlines 2026 net revenue guidance of $116M–$121M while expanding distributor network and product reach - MSN

May 08, 2026
pulisher
May 07, 2026

Sanara MedTech faces securities fraud probe after $31.2M loss and program shutdown. - Pluang

May 07, 2026
pulisher
May 07, 2026

SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire

May 07, 2026
pulisher
May 05, 2026

2,804 SMTI restricted shares granted to controller Ashley Mackey - Stock Titan

May 05, 2026
pulisher
May 05, 2026

How Sanara MedTech (SMTI) Is Reframing Its Growth Story Around A Steady US$34 Target - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

SMTI SEC FilingsSanara Medtech Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 05, 2026

Sanara Medtech Inc Stock (SMTI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
BAX BAX
$19.18
price up icon 0.79%
$163.61
price up icon 0.35%
COO COO
$62.55
price down icon 0.48%
$76.83
price up icon 0.10%
WST WST
$316.42
price up icon 0.09%
RMD RMD
$208.05
price down icon 0.45%
Cap:     |  Volume (24h):